Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bio Green Med Solution, Inc.CYCC · Entity 8225 | Chief Medical Officer | June 30, 2023 | July 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bio Green Med Solution, Inc.
Report date June 30, 2023 · Filed July 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.59 · Expires 2033-06-30 | Direct | 70,200 |
Reported balance
After 2023-06-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-30 · Grant · Acquired 70,200 · Balance 70,200 F1: The reporting person received an award of 70,200 options on June 30, 2023, which shall vest in full on June 30, 2026, provided, however, that if certain clinical milestones are achieved then such options shall vest in full earlier in connection with such achievement. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received an award of 70,200 options on June 30, 2023, which shall vest in full on June 30, 2026, provided, however, that if certain clinical milestones are achieved then such options shall vest in full earlier in connection with such achievement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2023 Filed Jul 3, 2023 20:56 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantStock Option (right to buy) · Derivative | 70,200 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001104659-23-077656 · tm2320411-5_4seq1.xml · derivative · entry 1 Kirschbaum Mark · CIK 0001830211 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,200 Underlying: Common Stock · 70,200 shares Expires 2033-06-30 F1 · price: The reporting person received an award of 70,200 options on June 30, 2023, which shall vest in full on June 30, 2026, provided, however, that if certain clinical milestones are achieved then such options shall vest in full earlier in connection with such achievement. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 21:17 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantCommon Stock | 31,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-009908 · tm235262-1_4seq1.xml · nonDerivative · entry 1 Kirschbaum Mark · CIK 0001830211 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,200 F1 · shares: The reporting person received an award of 31,200 restricted stock units on January 31, 2023, which shall vest in full on January 31, 2026, provided, however, that if certain clinical milestones are achieved then such restricted stock units shall vest in full earlier in connection with such achievement. Read SEC document |
| December 13, 2021 Filed Dec 15, 2021 21:18 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $3.45 | $0.00 |
DisclosureSEC source: 0001104659-21-150000 · tm2135363d1_4.xml · derivative · entry 1 Kirschbaum Mark · CIK 0001830211 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-12-13 F2 · price: These securities were granted as part of the Issuer's annual compensation review to executive officers. F1 · derivative.exercise_date: These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis. Read SEC document |
| October 23, 2020 Filed Oct 28, 2020 20:12 UTC | Bio Green Med Solution, Inc. CYCC · Entity 8225 | GrantStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $3.77 | $0.00 |
DisclosureSEC source: 0001104659-20-118939 · tm2034345d2_4.xml · derivative · entry 1 Kirschbaum Mark · CIK 0001830211 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2030-10-23 F1 · derivative.exercise_date: The shares underlying this option vest as to 40,000 shares on October 23, 2021, with the remainder vesting in 24 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.